Medical device maker Medtronic plcMDT recently announced the receipt of FDA approval for its Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan device for the treatment ...

PLATINIUM, released simultaneously in both Europe and Japan by LivaNova (formerly Sorin Group), will protect patients from avoidable replacement surgeries and the inherent risk of complications.

“This new device platform provides a number of new features that will help me to improve management of my patients with ICD and CRT-D devices, while delivering new safety features on top of St. Jude ...

On the heels of a unanimous FDA panel recommendation in March for an expanded indication of Boston Scientific's (Natick, Massachusetts) cardiac resynchronization therapy defibrillators (CRT-Ds), ...

The ENDURALIFE battery technology (Boston Scientific) is designed to extend the battery life of Boston Scientific cardiac resynchronisation therapy-defibrillator (CRT‑D) devices. CRT‑Ds are a ...

RMH electrophysiologist Robert VerNooy, MD, has successfully implanted a new type of heart pacing device that helps doctors better treat patients diagnosed with heart failure. He is the first ...

The company identified 7 studies that incorporated a cost-effectiveness analysis. It did not rely on these economic studies for its model, but the structure of the de novo model is similar to that ...

Medtronic announced Friday that FDA has approved the the first MR-conditional cardiac resynchronization therapy defibrillators (CRT-Ds) for the treatment of heart failure in the U.S. The Medtronic ...

CHICAGO, IL — Almost nine in 10 patients implanted with defibrillators who were also eligible for cardiac resynchronization therapy (CRT) actually did receive the pacing therapy in a US nationwide ...

Dallas, TX - The largest-yet analysis of its kind supports the use of cardiac resynchronization therapy (CRT), either with or without defibrillator backup, in patients with NYHA class 4 heart failure, ...